The first giant cell arteritis hospital quality standards (GHOST)-Reference-Cited by-同舟云学术

The first giant cell arteritis hospital quality standards (GHOST)

Published:2023-06-21 Issue:1 Volume:38 Page:1-3
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Bilton Edward J.^ORCID,Coath Fiona,Patil Ajay,Jones Colin,O’Sullivan Eoin,Hingorani Melanie^ORCID,Mukhtyar Chetan,Mollan Susan P.^ORCID

Funder

Roche

UCB | UCB UK

Invex Therapeutics Gensight Heidelberg engineering Chugai-Roche Ltd Allergan Santen Chiesi Santhera

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-023-02604-x.pdf

Reference10 articles.

1. Bilton EJ, Mollan SP. Giant cell arteritis: reviewing the advancing diagnostics and management. Eye (Lond). 2023:1–9. https://doi.org/10.1038/s41433-023-02433-y.

2. Mansfield-Smith S, Al-Hashim M, Jones C, Mukhtyar C. Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis. Clin Med (Lond). 2023;23:206–12.

3. Mollan SP, Begaj I, Mackie S, O’Sullivan EP, Denniston AK. Increase in admissions related to giant cell arteritis and polymyalgia rheumatica in the UK, 2002–13, without a decrease in associated sight loss: potential implications for service provision. Rheumatology (Oxford). 2015;54:375–7.

4. Kay L, Lanyon P. Rheumatology: GIRFT Programme National Specialty Report. England, 2021. https://gettingitrightfirsttime.co.uk/wp-content/uploads/2021/09/Rheumatology-Jul21h-NEW.pdf. Accessed April 2023.

5. Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary. Rheumatology (Oxford). 2020;59:487–94.